FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer
Clinical trial NCT01688336 · TERMINATED
Trial details
- NCT number
- NCT01688336
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2016-08-22
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.